133 related articles for article (PubMed ID: 9565562)
1. Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides.
Schneider B; Xu YW; Sellam O; Sarfati R; Janin J; Veron M; Deville-Bonne D
J Biol Chem; 1998 May; 273(19):11491-7. PubMed ID: 9565562
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of phosphorylation of anti-HIV D4T by nucleoside diphosphate kinase.
Schneider B; Biondi R; Sarfati R; Agou F; Guerreiro C; Deville-Bonne D; Veron M
Mol Pharmacol; 2000 May; 57(5):948-53. PubMed ID: 10779378
[TBL] [Abstract][Full Text] [Related]
3. NDP kinase reactivity towards 3TC nucleotides.
Kreimeyer A; Schneider B; Sarfati R; Faraj A; Sommadossi JP; Veron M; Deville-Bonne D
Antiviral Res; 2001 May; 50(2):147-56. PubMed ID: 11369435
[TBL] [Abstract][Full Text] [Related]
4. Cellular phosphorylation of anti-HIV nucleosides. Role of nucleoside diphosphate kinase.
Bourdais J; Biondi R; Sarfati S; Guerreiro C; Lascu I; Janin J; Véron M
J Biol Chem; 1996 Apr; 271(14):7887-90. PubMed ID: 8626464
[TBL] [Abstract][Full Text] [Related]
5. Catalytic mechanism of nucleoside diphosphate kinase investigated using nucleotide analogues, viscosity effects, and X-ray crystallography.
Gonin P; Xu Y; Milon L; Dabernat S; Morr M; Kumar R; Lacombe ML; Janin J; Lascu I
Biochemistry; 1999 Jun; 38(22):7265-72. PubMed ID: 10353838
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of anti-HIV nucleoside analogs by nucleoside diphosphate kinase.
Schneider B; Xu Y; Sellam O; Sarfati R; Janin J; Véron M; Deville-Bonne D
Nucleosides Nucleotides; 1999; 18(4-5):829-30. PubMed ID: 10432686
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of nucleoside diphosphate kinase at the active site studied by steady-state and time-resolved fluorescence.
Deville-Bonne D; Sellam O; Merola F; Lascu I; Desmadril M; Véron M
Biochemistry; 1996 Nov; 35(46):14643-50. PubMed ID: 8931563
[TBL] [Abstract][Full Text] [Related]
8. 3'-Phosphorylated nucleotides are tight binding inhibitors of nucleoside diphosphate kinase activity.
Schneider B; Xu YW; Janin J; Véron M; Deville-Bonne D
J Biol Chem; 1998 Oct; 273(44):28773-8. PubMed ID: 9786875
[TBL] [Abstract][Full Text] [Related]
9. Role of nucleoside diphosphate kinase in the activation of anti-HIV nucleoside analogs.
Schneider B; Sarfati R; Deville-Bonne D; Véron M
J Bioenerg Biomembr; 2000 Jun; 32(3):317-24. PubMed ID: 11768316
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide specificity of HIV-1 reverse transcriptases with amino acid substitutions affecting Ala-114.
Cases-González CE; Menéndez-Arias L
Biochem J; 2005 Apr; 387(Pt 1):221-9. PubMed ID: 15548134
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of human nucleoside-diphosphate kinase revealed by transient kinetic analysis.
Schaertl S; Konrad M; Geeves MA
J Biol Chem; 1998 Mar; 273(10):5662-9. PubMed ID: 9488696
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
13. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
Kerr SG; Anderson KS
Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
[TBL] [Abstract][Full Text] [Related]
14. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
Ueno T; Mitsuya H
Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide affinity for a stable phosphorylated intermediate of nucleoside diphosphate kinase.
Schneider B; Norda A; Karlsson A; Veron M; Deville-Bonne D
Protein Sci; 2002 Jul; 11(7):1648-56. PubMed ID: 12070317
[TBL] [Abstract][Full Text] [Related]
16. Improving nucleoside diphosphate kinase for antiviral nucleotide analogs activation.
Gallois-Montbrun S; Schneider B; Chen Y; Giacomoni-Fernandes V; Mulard L; Morera S; Janin J; Deville-Bonne D; Veron M
J Biol Chem; 2002 Oct; 277(42):39953-9. PubMed ID: 12171931
[TBL] [Abstract][Full Text] [Related]
17. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP.
Ostermann N; Lavie A; Padiyar S; Brundiers R; Veit T; Reinstein J; Goody RS; Konrad M; Schlichting I
J Mol Biol; 2000 Nov; 304(1):43-53. PubMed ID: 11071809
[TBL] [Abstract][Full Text] [Related]
18. Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma.
Lim SE; Copeland WC
J Biol Chem; 2001 Jun; 276(26):23616-23. PubMed ID: 11319228
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation.
Reardon JE
Biochemistry; 1992 May; 31(18):4473-9. PubMed ID: 1374638
[TBL] [Abstract][Full Text] [Related]
20. Activation of anti-reverse transcriptase nucleotide analogs by nucleoside diphosphate kinase: improvement by alpha-boranophosphate substitution.
Schneider B; Meyer P; Sarfati S; Mulard L; Guerreiro C; Boretto J; Janin J; Véron M; Deville-Bonne D; Canard B
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):297-306. PubMed ID: 11563041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
